Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study

• CHAUFFERT B

収録刊行物

• Ann Oncol

  Ann Oncol 19 (9), 1592-1599, 2008

詳細情報

• CRID: 1573668925543994624
• NII論文ID: 10030951157
• データソース種別:
  • CiNii Articles